Clinical Trials Logo

Pre-pandemic Influenza Vaccine clinical trials

View clinical trials related to Pre-pandemic Influenza Vaccine.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00848029 Completed - Clinical trials for Pre-pandemic Influenza Vaccine

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

Start date: November 2008
Phase: Phase 3
Study type: Interventional

The present study will evaluate the immunogenicity, safety and immunogenicity of two doses of monovalent inactivated influenza vaccine that is adjuvanted with MF59C.1 (MF59) and uses a surface antigen from a potential pandemic virus strain candidate (H5N1) in Adult Subjects.